Last updated: May 21, 2023
Sponsor: Tel Aviv University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Attention Deficit/hyperactivity Disorder (Adhd - Adults)
Williams Syndrome
Treatment
The efficacy of Equine Assisted Occupational Therapy, for children with Attention Deficit Hyperactivity Disorder (ADHD) on cognitive-emotional aspects, daily function and participation
Clinical Study ID
NCT05869253
0003949-2
Ages 6-12 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Children between 6 and 12 years of age
- Diagnosis of ADHD from a medical professional based on DSM-5 criteria with or withoutmedication (e.g., psychostimulant medication)
- General doctors' approval and referral for participating in EAS
Exclusion
Exclusion Criteria:
- Moderate to severe cognitive impairment
- Neurological disorders (e.g., epilepsy)
- Children with additional developmental disorders (e.g., Autism, Cerebral Palsy)
- Children who will begin new medicine treatment or change existing treatment duringintervention
- Children with severe sensory loss (e.g., blindness).
Study Design
Total Participants: 40
Treatment Group(s): 1
Primary Treatment: The efficacy of Equine Assisted Occupational Therapy, for children with Attention Deficit Hyperactivity Disorder (ADHD) on cognitive-emotional aspects, daily function and participation
Phase:
Study Start date:
February 01, 2023
Estimated Completion Date:
June 01, 2025
Study Description
Connect with a study center
Tel Aviv University
Tel Aviv, 69978
IsraelActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.